View Single Post
Old 07-04-2008, 12:46 AM   #6
Chelee
Senior Member
 
Chelee's Avatar
 
Join Date: Feb 2006
Location: Southern, CA
Posts: 2,511
Goops, I'm with Chrisy on this one...it really could be something totally benign. Since they look at our scans so hard many times they find these false positives. I am a stage IIIA with 5 positive nodes. One of my PET/CT's showed my hips light up. I was freaking out. (Especially since my hips were both killing me.) But thank goodness it was nothing.

So as hard as it is...try not to go to that dark place. I know every time I get a scare I try to make sure I don't borrow trouble. I've had several of them and its not fun as you already know. But try to stay busy and keep your mind on other things. Only think positive for now. (Easier said then done...I know!) They do have to look hard as you said due to your history...but that does not mean for sure its going to be bad news. Remember...one day at a time. Here's wishing you a very HAPPY 4TH OF JULY. I will be keeping you in my thoughts and prayers. You hang in there!

Chelee
__________________
DX: 12-20-05 - Stage IIIA, Her2/Neu, 3+++,Er & Pr weakly positive, 5 of 16 pos nodes.
Rt. MRM on 1-3-06 -- No Rads due to compromised lungs.
Chemo started 2-7-06 -- TCH - - Finished 6-12-06
Finished yr of wkly herceptin 3-19-07
3-15-07 Lt side prophylactic simple mastectomy. -- Ooph 4-05-07
9-21-09 PET/CT "Recurrence" to Rt. axllia, Rt. femur, ilium. Possible Sacrum & liver? Now stage IV.
9-28-09 Loading dose of Herceptin & started Zometa
9-29-09 Power Port Placement
10-24-09 Mass 6.4 x 4.7 cm on Rt. femur head.
11-19-09 RT. Femur surgery - Rod placed
12-7-09 Navelbine added to Herceptin/Zometa.
3-23-10 Ten days of rads to RT femur. Completed.
4-05-10 Quit Navelbine--Herceptin/Zometa alone.
5-4-10 Appt. with Dr. Slamon to see what is next? Waiting on FISH results from femur biopsy.
Results to FISH was unsuccessful--this happens less then 2% of the time.
7-7-10 Recurrence to RT axilla again. Back to UCLA for options.
Chelee is offline   Reply With Quote